Signaling through the interleukin 2 receptor (IL-2R) involves phosphorylation of several proteins including Jak3, STAT5, and, in preactivated cells, STAT3. In the present study, we examined the functional status of the IL-2R-associated Jak/STAT pathway in malignant T lymphocytes from advanced skin-based lymphomas: anaplastic large T-cell lymphoma (ALCL) and Sezary syndrome (SzS 
The basal activation of the Jak/STAT pathway involved in IL-2R signal transduction in ALCL and SzS cells reported here suggests that this pathway may play a role in the pathogenesis of cutaneous T-cell lymphomas, although the mechanism (induced versus constitutive) may vary between different lymphoma types.
High-affinity interleukin 2 receptor (IL-2R) is composed of three chains: a which is specific for IL-2, 13, and common y ( yc; refs. 1 and 2). The -yc is also a component of receptors for several other cytokines (3) (4) (5) . Together with the same 13 chain and a different, IL-15-specific a chain, -yc forms a fully functional IL-15R (6) (7) (8) (9) . Finally, yc codimerized with the respective cytokine-specific chains transduces signals mediated by IL-4, IL-7, and IL-9 (10) (11) (12) (13) . Intact structure and function of the yc is fundamental for the proper maturation and activation of T lymphocytes and other cells of the immune system since mutations of the yc gene lead to the X-linked severe combined immunodeficiency syndrome in both men (1, 14) and mice (15) (16) (17) . Interaction of the cytokine receptors such as IL-2R with their ligands induces activation of the intracellular tyrosine kinases (2, 18) . The cytoplasmic domain of the -yc chain is associated with the tyrosine kinase Jak3, whereas the 13 chain is associated with Jakl (19, 20) . Binding of IL-2 to the IL-2R results in activation of these two kinases and tyrosine phosphorylation of several substrates, including Jak3 and Jakl themselves, as well as the IL-2R yc and 1 chains (21, 22) . The phosphorylated IL-2R chains recruit proteins such as STAT5 (23) (24) (25) and, in phytohemagglutinin (PHA)-preactivated T-cell blasts, STAT3 (24, 26) . The STATs, upon phosphorylation, presumably by the Jaks, translocate into the nucleus and bind to DNA to initiate transcription of IL-2 responsive genes. Involvement of Jak3 is crucial for transduction of signals mediated by yc because mutations of Jak3 result in severe immunodeficiency in patients (27, 28) and mice (29, 30) , which mimics that seen in mutations of the yc chain (1, (14) (15) (16) (17) . Some of the signals mediated by the IL-2R can be inhibited by rapamycin (31) , which appears to exert this inhibition by interfering with induction of bcl-2 (32) .
Cutaneous T-cell lymphoma (CTCL) is the most frequent lymphoma occurring in the skin (33, 34) . At presentation, CTCL is usually an indolent, low-grade tumor composed of atypical T lymphocytes with small to medium-sized hyperchromatic and highly irregular (cerebriform) nuclei (35, 36) . CTCL has a tendency to progress over time. When it spreads into the blood, the diagnosis of Sezary syndrome (SzS) is made (37) (38) (39) . Progression to a high-grade lymphoma (35, 36) composed of cells with large nuclei and sometimes anaplastic features also occurs, leading to the diagnosis of the secondary (anaplastic) large T-cell lymphoma (ALCL).
Because signals mediated through IL-2R are so important in activation of normal T cells, we examined the functional status of IL-2R-associated Jak/STAT signal transduction pathway in malignant T cells from the lymphomas involving skin. Our data demonstrate that this pathway shows basal activation, respectively constitutive and induced, in cells from ALCL and SzS. IL-2R signal transduction pathway may therefore play a role in the pathogenesis of cutaneous T-cell malignancies, although the mechanism of its activation may be different between these lymphoma types.
MATERIALS AND METHODS
Cell Lines. Three cell lines (PB-1, 2A, and 2B), established from a patient with a progressive cutaneous T-cell lymphoproliferative disorder have been described in detail (41, 42) . In Proc. Natl. Acad. Sci. USA 93 (1996) 9149 brief, the PB-1 cell line was obtained at a relatively early stage of the patient's cutaneous T lymphoma from neoplastic T cells circulating in peripheral blood. The 2A and 2B lines were established at a later, aggressive stage from two separate skin nodules, which represented a high-grade, T-cell ALCL. The common clonal origin of all three T-cell lines was demonstrated by cytogenetics and T-cell receptor gene rearrangement (41) . The same clone was found in patient's lymphoma tissues. The cell lines were also similar to fresh biopsy specimens in regard to morphology and immunophenotype (42) and retained in culture features of the original lymphoma. LCL is a lymphoblastoid B-cell line obtained from the same patient as the PB-1, 2A, and 2B lines, by in vitro infection with EpsteinBarr virus. The SZ-4 line, kindly provided by T. Abrams (Hahnemann University), was derived from a SzS patient and bears close morphological, phenotypic, and genotypic resemblance to the original tumor (43) . Growth of the SZ-4 line is IL-2 dependent. The human NK (YT) cell line (44) was kindly provided by J. Yodoi (Kyoto University). All the cell lines were propagated in complete RPMI 1640/10% FBS medium (42 Flow-Cytometry Analysis Flow cytometry for expression of IL-2R a, ,B, and yc chains was performed by direct and indirect immunostaining as described (40, 45) . In brief, cells were stained at 4°C with the appropriate Ab, either PE-conjugated (anti-a and -j3) or unconjugated (goat anti--yc) Ab, which was followed by a secondary, PE-conjugated F(ab')2 fragment of the donkey-anti-goat Ab (46) . In the first, T cells receive signals through the T-cell receptor complex and receptors for costimulatory molecules. In the second stage, they respond to cytokines such as IL-2. To determine which of these activation pathways is important in the growth of malignant T cells, the three ALCL-derived T-cell lymphoma lines (PB-1, 2A, and 2B) were exposed to several immunosuppressive agents. As shown in Fig. 1 (Fig. 3A) . detectable (Fig. 3 B-D) . The pattern of phosphorylation of these proteins, particularly of Jak3, was similar to the one of Jakl. The PB-1 line required IL-2 for maximal Jak3 phosphorylation, whereas the 2A and 2B lines showed constitutive, maximal phosphorylation, nonresponsive to stimulation with IL-2 (Fig. 3C) . Basal phosphorylation of STAT3 (Fig. 3C) and STAT5 (Fig. 3D ) appeared maximal in all three lines. The control, Epstein-Barr virus-transformed B-cell LCL line derived from the same patient did not show phosphorylation of any of these Jak and STAT proteins, either basal or after exposure to IL-2 ( Fig. 3 C and D , and data not shown). Because Jak3 associates with, and presumably phosphorylates, IL-2R'yc (19, 20) , we also determined the phosphorylation status of the yc in the PB-1 and 2B lines (Fig. 3E) . As with Jak3, PB-1 showed weak basal phosphorylation of the yc, significantly enhanced by exposure of the cells to IL-2. The 2B line showed Proc. Natl. Acad. Sci. USA 93 (1996) 9151 a similarly weak band in nonstimulated cells, which was moderately enhanced by stimulation with IL-2. Associations Among Jak3, STAT5, and STAT3 Proteins. To determine if there were associations between the Jak and STAT proteins involved in IL-2R-mediated signal transduction in the malignant T lymphocytes studied here, we performed several coprecipitation experiments (Fig. 4) . Immunoprecipitation with anti-STAT5 antibody, followed by immunoblotting with anti-Jak3 antibody, resulted in visualization of the Jak3 protein (Fig. 4A) . Jak3 could be detected in the PB-1, 2A, and 2B lines in both IL-2 nonexposed and exposed cells. This finding documents constitutive association between Jak3 and STAT5 in these ALCL-derived T cells. Similar constitutive association was found in between Jak3 and STAT3 (Fig. 4B ) and STAT5 and STAT3 (Fig. 4C) .
Phosphorylation of IL-2R-Associated Jak/STAT Proteins in Freshly Isolated Cells from Patients with SzS. To determine if activation of the IL-2R-associated signal transduction pathway observed in the ALCL-derived malignant T cells is also present in SzS cells, we tested phosphorylation of Jak3, STAT3, and STAT5 proteins in freshly isolated PBMC from 14 patients with SzS. Results from one, representative patient (patient 2) are shown in Fig. SA , and the data from all patients are summarized in Table 1 . As can be seen in Table 1 , PBMC from 10 of 14 patients showed phosphorylation of Jak3 without exposure to IL-2. Stimulation by IL-2 either markedly enhanced this basal Jak3 phosphorylation or induced it in the 4 patients who were negative without IL-2 stimulation. Nine of the 10 patients who displayed the basal Jak3 phosphorylation also showed basal, frequently weak, phosphorylation of STAT5, and 4 showed phosphorylation of STAT3. Similar to Jak3 phosphorylation, IL-2 usually had an augmenting and/or inducing effect on STAT3 and STAT5 phosphorylation. As expected, the control, normal PBMC and PHA-stimulated blasts required IL-2 stimulation to phosphorylate, respectively, Jak3 and STAT5, and Jak3, STAT5, and STAT3 proteins.
Phosphorylation of IL-2R-Associated Jak/STAT Proteins in Short-Term Cultured Cells from SzS Patients. There are at least two possible, alternative mechanisms responsible for the (35, 36, 49) . SzS, however, is usually a low-grade lymphoma with a more prolonged course, less atypical, small to medium-sized cells, and generally less complex, immunophenotype, and karyotype (35, 36, 49) . Also, the ALCL-derived PB-1, 2A, and 2B T-cell lines are virtually identical to the original lymphoma cells as determined by morphologic, immunologic, cytogenetic, and molecular criteria (41, 42) . The cell lines are also very stable in culture as shown by the repeated immuno-and cytogenetic phenotyping. Furthermore, the PB-1 cell line, which was derived from a clinically less-aggressive stage of the patient's disease displayed only a partial basal activation of the Jak3, which could be augmented by IL-2, whereas the 2A and 2B lines, from a highly aggressive stage of the same lymphoma, showed maximal basal activation of Jak3, nonresponsive to IL-2. Thus, PB-1 may represent an "intermediate" activation status of the IL-2R related Jak/STAT pathway, which is consistent with the other features of this line. Finally, the SzS-derived SZ-4 cell line required IL-2 for proliferation and activation of Jak3 and Stat 5 proteins similar to the freshly isolated SzS cells.
The dependence of SzS-derived lines on exogenous cytokines has also been noted by others (50) . It appears, therefore, that low-grade T-cell lymphomas of the skin may still be dependent on autocrine or paracrine cytokines for their growth, whereas the high-grade tumors may become progressively independent of these factors. Evidence that SzS cells appear to produce cytokines of the Th2 type such as IL-4 (51) , and that ALCL cells do not produce IL-4 or IL-2 (42, 52, 53) , is consistent with such an explanation. Furthermore, the 2A and 2B cell lines studied here express less IL-2R than the PB-1 line (Fig. 2 and ref. 42 ), despite the fact that they show strong basal phosphorylation of the Jak/STAT proteins (Fig. 3) . This finding also argues against an autocrine cytokine that utilizes the IL-2R or its components (e.g., yc) being responsible for the constitutive phosphorylation of the Jak/STAT proteins in the more advanced tumors. Similar constitutive activation of Jak/ STAT proteins involved in IL-2R-mediated signal transduction was reported recently in human T-lymphotropic virus, type I (HTLV-I)-positive, transformed T-cell lines (54) . Although HTLV-I, and particularly the tax protein, has T-cell activating properties (55) , its role in Jak/STAT phosphorylation in these lines remains to be examined. HTLV-I is not responsible for the constitutive Jak/STAT phosphorylation in the ALCL cells we have studied, since PB-1, 2A, and 2B cells do not contain the HTLV-I DNA (M. Wasik, unpublished data) and there is currently no evidence for association between ALCL and HTLV-I. Clearly, further studies, such as search for potentially oncogenic mutation(s) of the proteins involved in the IL-2R-mediated signal transduction are needed to understand the nature of the basal, constitutive activation of the Jak/STAT pathway in these various populations of neoplastic T cells.
In conclusion, our finding that the IL-2R-associated Jak/ STAT signal transduction pathway is activated in ALCL and SzS-derived cells suggests that this pathway may play a role in the pathogenesis of cutanous T-cell lymphomas. The mechanism of this activation-induced versus constitutive-may be lymphoma-grade dependent. The recent finding that a novel, Jak-specific inhibitor suppresses growth of Jak2-phosphorylation dependent cell lines derived from patients with acute lymphoblastic leukemia (56) suggests that a similar approach that targets Jak3 might be considered in SzS and ALCL.
